CVS Caremark Corporation approves new share repurchase programme.
M2 PHARMA-September 20, 2012-CVS Caremark Corporation approves new share repurchase programme(C)2012 M2 COMMUNICATIONS
CVS Caremark Corporation (NYSE: CVS), a large integrated pharmacy company in the US, announced yesterday that the company's board of directors has approved a new share repurchase programme for up to USD6bn of the firm's outstanding common stock.
Effective immediately, the share repurchase authorisation allows the firm to impact the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
The company expects the new share repurchase programme to be completed over a multi-year period.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Date:||Sep 20, 2012|
|Previous Article:||China Botanic Pharmaceutical Inc reports third quarter financial results.|
|Next Article:||Medicure Inc reports financial results for fiscal 2012.|